| 标题 |
 Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
极限001
invisight
null
乐空思
DW
v0id
酸味yjm
xing_xing
花开富贵
子安
kaio_escolar
Elsevier大王
maxiaole
真没招了
aaaa
GingerF
Youdge
zhixiang
mmmm
皖公网安备34019202002308
